Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Impot Res ; 23(4): 146-50, 2011.
Article in English | MEDLINE | ID: mdl-21654813

ABSTRACT

We sought to identify factors influencing dose maintenance of intracavernous (IC) injection among patients with ED following radical prostatectomy. A total of 93 patients underwent prostatectomy and received IC treatment for ED, including PGE1 single therapy (n=53) and triple therapy (n=40). In the PGE1-only group, the maintenance dosage was significantly correlated with preoperative sexual function and nerve sparing (NS) (P<0.05). For example, the maintenance dose among patients with no, unilateral and bilateral NS was 10.8 ± 6.6 µg (0.54 ± 0.33 ml), 10.8 ± 3.8 µg (0.54 ± 0.19 ml) and 6.4 ± 4.6 µg (0.32 ± 0.23 ml), respectively. In terms of preoperative sexual function, the maintenance dose among non-ED versus ED patients was 0.38 ± 0.25 ml (7.6 ± 5.0 µg) and 0.59 ± 0.31 ml (11.8 ± 6.2 µg), respectively. No significant correlation was observed between the maintenance dose and NS or preoperative sexual function among the triple-therapy patients or between the maintenance dose and age, body mass index, systemic diseases and initiation of ED treatment among all patients (P>0.05). Thus, maintenance dose of PGE1 therapy could be partly determined by NS status and prior ED of patients.


Subject(s)
Alprostadil/administration & dosage , Erectile Dysfunction/therapy , Vasodilator Agents/administration & dosage , Adrenergic alpha-Antagonists/administration & dosage , Drug Therapy, Combination , Erectile Dysfunction/etiology , Humans , Injections , Male , Middle Aged , Papaverine/administration & dosage , Phentolamine/administration & dosage , Prostatectomy/adverse effects , Retrospective Studies
2.
Rev Esp Enferm Dig ; 102(7): 447-8, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20617867

ABSTRACT

We report a 52-year-old male with no family history of colonic cancer, who was found to have advanced colonic cancer with metastases two months post renal transplantation. With this case, we highlight the possibility of acute fulminant cancer metastases within short period after renal transplantation and the importance of periodic colorectal cancer screening pre-transplant. To our knowledge, this case is not yet reported in the literature, especially with such presentation of acute fulminant colonic cancer metastases post renal transplantation.


Subject(s)
Adenocarcinoma/secondary , Colonic Neoplasms/pathology , Kidney Transplantation , Liver Neoplasms/secondary , Postoperative Complications/pathology , Splenic Neoplasms/secondary , Acute Disease , Humans , Male , Middle Aged
3.
Transplant Proc ; 40(7): 2299-302, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18790218

ABSTRACT

BACKGROUND: Despite the ever-lengthening renal transplant waiting lists, without more donors, living donors serve as a treatment option for patients on dialysis. In the past, patients of advanced age were not considered to be candidates for living donor renal transplantation. Therefore, this study sought to analyze whether older age affects the outcome of living donor renal transplantation. METHODS: A total of 527 primary living donor renal transplantations were performed between January 1, 1995 and January 1, 2006. The subjects were divided into 2 subgroups based on patient age at the time of transplantation. The elder group included all recipients at least 60 years vs the control group of younger patients. RESULTS: Significant differences were observed in readmission rate (elder group, 44%; young group, 31.33%; P = .031) and patient survival rate (P < .001). No significant difference was noted in graft survival rate (P = .201), acute rejection rate (elder group, 10.6%; young group, 13.3%; P = .7), serum creatinine level, or length of stay (elder group, 8.51 days; young group, 6.31 days; P = .083). CONCLUSIONS: Our results confirm that elder patients may benefit from living donor renal transplantation.


Subject(s)
Kidney Transplantation/physiology , Living Donors , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Follow-Up Studies , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Kidney Transplantation/immunology , Middle Aged , Retrospective Studies , Treatment Outcome
4.
Asian J Androl ; 6(3): 273-6, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15273879

ABSTRACT

AIM: To determine the long-term outcome, effectiveness and patient satisfaction of congenital penile curvature correction by plication of tunica albuginea. METHODS: From January 1992 to January 2002, 106 young patients underwent surgical correction of congenital penile curvature by corporeal plication. Indications for operation were difficult or impossible vaginal penetration and cosmetic problems. The technique of corporeal plication consists of placing longitudinal plication sutures of 2-zero braided polyester on the convex side of the curvature until the curvature is corrected when erection is artificially induced. Results of this procedure were obtained by retrospective chart reviews and questionnaires via mail. Long-term follow-up ranged from 11 to 132 (mean 69.3) months and data were available for 68 patients. RESULTS: Penile straightening was excellent in 62 patients (91 %) and good with less than 15 degree of residual curvature in 6 patients (9 %). Sixty-seven patients reported no change in erectile rigidity or maintenance postoperatively, while 1 described early detumescence. Shortening of the penis without functional problems was noted by 26 patients (38 %). Thirty-Five patients (51 %) reported feeling palpable indurations (suture knots) on the penis. Temporary numbness of glans penis was described in 3 patients. Overall, 60 patients were very satisfied, 6 satisfied, 2 unsatisfied. CONCLUSION: Corporeal plication is an effective and durable procedure with a high rate of patient satisfaction.


Subject(s)
Penis/abnormalities , Penis/surgery , Adolescent , Adult , Follow-Up Studies , Humans , Male , Penile Erection , Retrospective Studies , Surgical Procedures, Operative , Treatment Outcome
5.
Arch Androl ; 50(3): 151-4, 2004.
Article in English | MEDLINE | ID: mdl-15204680

ABSTRACT

Blunt trauma to the pelvic or perineal region of the corpora cavernosa is a risk factor for the subsequent development of persistent erectile dysfunction. The hemodynamic investigation of the integrity of the veno-occlusive mechanism has been rare in cases of traumatic impotence. We present two young men with erectile dysfunction following blunt penile or perineal trauma. Combined intracavernous injection and stimulation test, color duplex ultrasonography, and pharmacologic cavernosometry and cavernosography revealed normal arterial velocity and pulsation without cavernosal arterial fistula, but severe venous occlusion and site-specific abnormal veins were noted in both patients. They received penile vein ligation procedure and resulted in near-completely normal erectile function after a four-year followup. Penile venous ligation, especially on the site-specific veins, is still the choice of treatment for the trauma-induced penile veno-occlusive erectile dysfunction, and the result is satisfactory.


Subject(s)
Impotence, Vasculogenic/etiology , Penis/injuries , Wounds, Nonpenetrating/complications , Humans , Male , Penile Erection , Penis/diagnostic imaging , Radiography , Ultrasonography
6.
Arch Androl ; 50(3): 201-5, 2004.
Article in English | MEDLINE | ID: mdl-15204688

ABSTRACT

Epidermoid cyst is a rare benign tumor of the testes. The records from the last 20 years of Taiwanese patients in whom a testicular tumor was diagnosed were reviewed retrospectively. Patients with a confirmed epidermoid cyst of testis were evaluated for age, clinical assessment and follow-up. Among a total 146 testicular tumors, 28 (19%) patients had a benign tumor including 15 patients (10%; mean age 23 years, range 17-32 years) with an epidermoid cyst diagnosed pathologically. Pre-operative suspicion of the benign nature of the lesions was supported by testicular ultrasonography in 11 patients. Seven patients underwent magnetic resonance imaging after which benign epidermoid cyst was impressed in five patients. A testicular-sparing operation was performed in 12 patients after frozen sections confirmed the diagnosis. Three patients were treated by radical orchiectomy. There was no relapse after a median follow-up of 42 months (range, 2-82 months). Ultrasonography and magnetic resonance imaging of the scrotum may allow the diagnosis of epidermoid cyst of the testes to be made pre-operatively. The absence of relapse in these patients further supports the use of organ sparing surgery in these young men.


Subject(s)
Epidermal Cyst , Testicular Diseases , Adolescent , Adult , Diagnosis, Differential , Epidermal Cyst/diagnosis , Epidermal Cyst/surgery , Humans , Magnetic Resonance Imaging , Male , Orchiectomy/methods , Retrospective Studies , Taiwan , Testicular Diseases/diagnosis , Testicular Diseases/surgery , Testis/pathology
7.
Arch Androl ; 49(6): 471-4, 2003.
Article in English | MEDLINE | ID: mdl-14555332

ABSTRACT

Records of 71 patients diagnosed with prostate cancer were reviewed retrospectively regarding clinical stage, prostate-specific antigen (PSA), Gleason score, CT scan of pelvis, bone scan, and pelvic lymph node dissection. Fourteen patients had pelvic lymphadenopathy based on the CT scan. Of these, no patient had a PSA level <4 ng/mL, 1 patient had a PSA level between 4 and 10 ng/mL, and 3 had a PSA level between 10 and 20 ng/mL. Twelve of 13 patients with positive bone scan results had a PSA level >20 ng/mL, and 1 patient had a PSA level between 10 and 20 ng/mL. PSA can be cost-effective in selecting and identifying appropriate staging for patients with newly diagnosed prostate cancer. CT scans are not indicated in men with clinical localized prostate cancer when PSA levels are < or =10 ng/mL. Bone scan is not required for staging asymptomatic men with PSA levels of < or =20 ng/mL. Pelvic lymphadenectomy for localized prostate cancer may not be necessary if PSA levels is < or =20 ng/mL and Gleason score is < or =5.


Subject(s)
Adenocarcinoma/secondary , Neoplasm Staging , Prostate-Specific Antigen/blood , Prostatic Neoplasms/pathology , Adenocarcinoma/blood , Adenocarcinoma/epidemiology , Humans , Lymph Nodes/pathology , Male , Prostatic Neoplasms/blood , Prostatic Neoplasms/epidemiology , Retrospective Studies , Taiwan/epidemiology
8.
Arch Androl ; 49(2): 129-37, 2003.
Article in English | MEDLINE | ID: mdl-12623749

ABSTRACT

To investigate whether the pre- and postoperative International Prostate Symptom Score (IPSS) change predicts the outcome of transurethral prostatectomy in a Taiwanese population, 99 patients (transurethral prostatectomy candidates) were assessed with the IPSS before and 6-12 months after surgery. All symptoms improved significantly postoperatively. Patients with a greater preoperative IPSS benefited the most. Improvements in preoperative obstructive symptoms (incomplete emptying, intermittency, straining, and weak stream) were greater than those in irritable symptoms (urgency, frequency, and nocturia). A significant correlation was found between IPSS and quality of life (QOL) before and after transurethral prostatectomy. A change of 1 unit on the IPSS scale was found to decrease the QOL score 0.282 units. The positive predictive value of a >or=7-IPSS point decrease depended on the predictive IPSS criteria applied. When the preoperative IPSS was more than 17, the sensitivity was 83.5% and specificity was 30%. Postoperative improvement did not differ significantly between acute urinary retention (AUR) and non-AUR patients. Change in IPSS of more than 7 points predicted symptomatic improvement with high sensitivity. The predictive value depends on the definition of significant improvement (magnitude of IPSS change) and on the level of IPSS symptoms (sufficient to warrant transurethral prostatectomy).


Subject(s)
Prostate/pathology , Prostatic Hyperplasia/pathology , Transurethral Resection of Prostate , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Postoperative Period , Preoperative Care , Prostatic Hyperplasia/surgery , Quality of Life , Severity of Illness Index , Taiwan , Treatment Outcome
9.
Arch Androl ; 48(2): 101-6, 2002.
Article in English | MEDLINE | ID: mdl-11868622

ABSTRACT

Aggressive angiomyxoma is a rare and nonmetastasizing soft tissue tumor of the pelvis and perineum and occurs almost exclusively in adult females. It infiltrates locally and has a high risk of local recurrence. Recommended treatment of the symptomatic patient is wide excision with tumor-free margins and close postoperative monitoring. Herein, a case of aggressive angiomyxoma in an adult male is described, which arose in the scrotum over 12 months. The tumor showed an intermediate signal on T1-weighted MRI images. Contrast-enhanced T1-weighted images showed good enhancement. Wide excision of the tumor was performed. The surgical specimen measured 7 x 5 x 5 cm in size and weighed 80 g. The tumor's surface was smooth and had a gelatinous cut surface. Grossly, it was encapsulated with a pleura-like membrane and had a finger-like projection. Microscopically, sections showed many walled vessels of various sizes, collagen fibrils, a loose myxoid background. and spindle stroma cells. MRI and CT showed the angiomatous and myxomatous nature of the tumor wall. To the authors' knowledge, this is the first report to describe MRI findings in scrotal angiomyxoma.


Subject(s)
Genital Neoplasms, Male/diagnosis , Myxoma/diagnosis , Scrotum , Adult , Genital Neoplasms, Male/pathology , Genital Neoplasms, Male/surgery , Humans , Magnetic Resonance Imaging , Male , Myxoma/pathology , Myxoma/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...